Asia’s Leading ADC R&D & Manufacturing Conference – Uniting Asia Leaders in Antibody- Drug Conjugates market

23 - 24 March 2027 Sands Expo & Convention Centre, Singapore

Part of Biopharma APAC Confex 2027

Co-located Events

Visit Brochure

Awards

About the Event

ADC Asia Congress 2027 is the region’s premier gathering dedicated to advancing Antibody-Drug Conjugates (ADCs), bringing together global innovators, biopharma leaders, researchers, manufacturers, investors, and solution providers from across the Asia-Pacific ecosystem. As ADCs continue to reshape the future of targeted cancer therapies, the congress serves as a strategic platform to explore the latest breakthroughs in discovery, conjugation technologies, payload development, manufacturing, clinical development, regulatory strategies, and commercialisation.

Designed to foster collaboration and accelerate innovation, the conference features high-level keynote presentations, technical case studies, panel discussions, and networking opportunities with leading pharmaceutical and biotechnology companies from across Asia and beyond. ADC Asia Congress 2027 offers attendees unparalleled access to industry insights, emerging trends, strategic partnerships, and business opportunities driving the next generation of precision medicine and oncology therapeutics.

What we'll cover

Key Themes

Asia’s Leadership in ADC Innovation

Highlighting Asia’s emergence as a global powerhouse in ADC R&D, fueled by biotech innovation, strategic partnerships, and late-stage clinical pipelines.

Next-Generation ADC Discovery & Design

Focus on pioneering novel targeting strategies, linker-payload technologies, and discovery platforms shaping the future of ADCs

Translational Excellence: From Bench to Bedside

Addressing the critical path from preclinical insights to successful clinical outcomes, and emphasizing safety, efficacy, and regulatory considerations.

Manufacturing, CMC & Quality Optimization

Showcasing innovative approaches in Chemistry, Manufacturing, and Controls (CMC), including process efficiency, quality control, and scale-up technologies.

Commercialization, Partnerships & Investment in Asia

Showcasing licensing, partnering, and funding strategies driving growth and commercialization success in the Asian ADC market.

BY THE NUMBERS

Our Impact in Asia's Biopharma

300+

Senior Attendees

Meet a highly concentrated audience of senior decision-makers, including VPs and Directors of ADC Early Development Bioconjugates/Bioconjugation, ADC Manufacturing & Process Development, Novel Modalities R&D, Heads of Toxicology and Pharmacokinetics, as well as Heads of Translational Medicine and Biology from leading biopharma hubs across the region.

100+

ADC Companies Represented

A high-level gathering of leading ADC developers, bioconjugation specialists, CDMOs, global biopharma players, innovative biotech companies, and technology providers across Asia’s key biopharma hubs.

40+

Expert Speakers

Hear from leading experts across Asia’s ADC landscape, including pioneers in ADC development, bioconjugation, manufacturing, process intensification, regulatory strategy, and next-generation therapeutic innovation. Gain insights from senior leaders driving advancement across the region’s top ADC companies and biopharma hubs.

Testimonials

Hear from past attendees and industry leaders

"The ADC Asia Congress provided an excellent platform for meaningful exchange. The strong emphasis on translating upstream innovation into manufacturing impact was particularly valuable."

Head of Biotherapeutics Process Development, Pharmaceutical Sciences

Takeda

Japan

"It was a very valuable conference experience. The meeting offered a strong scientific programme, and it was inspiring to hear high-quality work from other groups. Beyond the content itself, the conference was especially useful for building new connections."

CTO

Singzyme

Singapore

"Great experience! Nice speakers and exhibitions!"

CEO

HoneyBear Biosciences, Inc.

Taiwan

"Good selection of topics and speakers"

Senior Scientist, Bioprocessing Technology Institute

A*STAR

Singapore

"This 2nd ADC Asia Congress was well organized with lots of excellent speakers and informative materials. Well organized to ensure everyone in the ADC field to get to know the state of art in this fast growing field."

CEO

PinotBio

South Korea

"It was a fantastic experience speaking at the 2nd ADC Asia Congress. The event showcased cutting-edge advancements in the field and provided a valuable platform for meaningful discussions with key industry leaders. I look forward to seeing how this community continues to grow."

Senior Director and ADC MedChem Group Head

Innovent Biologics

China

Sponsors & Media Partners

Special thanks to our event partners, without whom we would not be able to provide this networking, learning, and collaborating platform.

Silver Sponsor

Bronze Sponsors

AGENDA AT A GLANCE

CONFERENCE DAY 1 \| 23rd March 2027	CONFERENCE DAY 2 \| 24th March 2027
Leadership Panel Discussion Building Asia’s Global Leadership in Biologics, ADCs & Novel Modalities	CMC, Analytics & Quality Achieving CMC Excellence, Integrated Analytics, Quality Control & Regulatory Readiness
Morning Break – Exhibition Viewing & 1-1 Attendees Networking
Discovery Innovative Pathways in ADC Discovery: Unlocking Next-Gen Targeting Strategies	Safety and Efficacy Balancing Safety and Efficacy in ADCs: Overcoming Challenges for Effective Treatment
Lunch – Exhibition Viewing & 1-1 Attendees Networking
Advancing Pre-Clinical Research Bringing the Gap: From Pre-Clinical Insights to Clinical Success in ADC Development	ADC Biopharma Showcase Pioneering Innovation and Excellence in Antibody-Drug Conjugates
Afternoon Break – Exhibition Viewing & 1-1 Attendees Networking
Formulation & Stability Ensuring ADC Stability & Optimized Formulation for Maximum Efficacy
Asia-Pacific Biopharma Excellence Awards 2027

CONFERENCE DAY 1 | 23rd March 2027

Leadership Panel Discussion

Building Asia’s Global Leadership in Biologics, ADCs & Novel Modalities

Discovery

Innovative Pathways in ADC Discovery: Unlocking Next-Gen Targeting Strategies

Advancing Pre-Clinical Research

Bringing the Gap: From Pre-Clinical Insights to Clinical Success in ADC Development

Formulation & Stability

Ensuring ADC Stability & Optimized Formulation for Maximum Efficacy

CONFERENCE DAY 2 | 24th March 2027

CMC, Analytics & Quality

Achieving CMC Excellence, Integrated Analytics, Quality Control & Regulatory Readiness

Safety and Efficacy

Balancing Safety and Efficacy in ADCs: Overcoming Challenges for Effective Treatment

ADC Biopharma Showcase

Pioneering Innovation and Excellence in Antibody-Drug Conjugates

CONFERENCE AGENDA

Day 1

23 March 2027

8:50

Chairman Opening Remarks

Leadership Panel Discussion: Building Asia’s Global Leadership in Biologics, ADCs & Novel Modalities

9:00

Leadership Panel Discussion: Asia’s Biologics Ambition: From Regional Manufacturing Hub to Global Innovation Powerhouse

Evaluating Asia’s competitive advantage in biologics development, manufacturing, and commercialization.
Identifying critical investments required in talent, infrastructure, and technology to compete globally.
Strengthening regional collaboration between governments, industry, academia, and investors.
Building resilient and future-ready biologics ecosystems capable of supporting next-generation therapeutics.

PANELISTS

Teck Chung Chang

VP, Site Quality Head, Takeda